Limited specificity of commercially available SARS‐CoV‐2 IgG ELISAs in serum samples of African origin

OBJECTIVES: Specific serological tests are mandatory for reliable SARS‐CoV‐2 diagnostics and seroprevalence studies. Here, we assess the specificities of four commercially available SARS‐CoV‐2 IgG ELISAs in serum/plasma panels originating from Africa, South America, and Europe. METHODS: 882 serum/pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Emmerich, Petra, Murawski, Carolin, Ehmen, Christa, von Possel, Ronald, Pekarek, Neele, Oestereich, Lisa, Duraffour, Sophie, Pahlmann, Meike, Struck, Nicole, Eibach, Daniel, Krumkamp, Ralf, Amuasi, John, Maiga‐Ascofaré, Oumou, Rakotozandrindrainy, Raphael, Asogun, Danny, Ighodalo, Yemisi, Kann, Simone, May, Jürgen, Tannich, Egbert, Deschermeier, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014856/
https://www.ncbi.nlm.nih.gov/pubmed/33666297
http://dx.doi.org/10.1111/tmi.13569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014856/
https://www.ncbi.nlm.nih.gov/pubmed/33666297
http://dx.doi.org/10.1111/tmi.13569

Ejemplares similares